Case ReportNon-adherence in Hypertension Management Deficit in Information or Trust?
References (29)
Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles
Am J Med
(1973)- et al.
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the american college of cardiology/american Heart association task force on practice guidelines
J Am Coll Cardiol
(2014) - et al.
High blood pressure: the leading global burden of disease risk and the need for worldwide prevention programs
Curr Hypertens Rep
(2013) - et al.
Heart disease and stroke statistics – 2014 update
Circulation
(2014) - et al.
Trends in mortality rates by subtypes of heart disease in the United States, 2000–2010
JAMA
(2014) - et al.
The production of persistent elevation of blood pressure by means of renal ischemia
J Exp Med
(1934) - et al.
The substance causing renal hypertension
J Physiol
(1940) - et al.
Activation of renin by blood colloids
Proc Soc Exp Biol
(1938) - et al.
Angiotensin
Physiol Rev
(1961) The role of aldosterone in man: evidence for regulation of electrolyte balance and arterial pressure by renal adrenal system which may be involved in malignant hypertension
JAMA
(1960)
Hemodynamic effects of angiotensin, norepinephrine and braykinin continuously measured in unanaesthetized dogs
Am J Physiol
(1961)
Cardiovascular effects of angiotensin mediated by the central nervous system
Circ Res
(1972)
Systemic compliance: does it play a role in the genesis of essential hypertension?
Cardiovasc Res
(1984)
Familial aggregation and genetic epidemiology of blood pressure
Cited by (0)
Financial disclosure: None.
Conflicts of interest and source of funding: None.
© 2016 by the National Medical Association. Published by Elsevier Inc. All rights reserved.